1264870-22-5 Usage
Description
(3-(4-aminophenyl)-5-methylisoxazol-4-yl)(4-(2-chloro-4-nitrophenyl)piperazin-1-yl)methanone is a complex organic molecule characterized by the presence of an isoxazole ring with a methyl and aminophenyl group, a piperazine ring with a chloro-nitrophenyl group, and a methanone functional group. Its structural features suggest potential pharmaceutical applications and possible biological activity, making it a candidate for further research and development in medicinal chemistry.
Uses
Used in Pharmaceutical Industry:
(3-(4-aminophenyl)-5-methylisoxazol-4-yl)(4-(2-chloro-4-nitrophenyl)piperazin-1-yl)methanone is used as a pharmaceutical compound for its potential medicinal properties. Its unique structure, including the isoxazole and piperazine rings along with the methanone group, may contribute to its biological activity, offering opportunities for the development of new drugs and therapies.
Used in Medicinal Chemistry Research:
In the field of medicinal chemistry, (3-(4-aminophenyl)-5-methylisoxazol-4-yl)(4-(2-chloro-4-nitrophenyl)piperazin-1-yl)methanone serves as a subject of study for understanding its chemical behavior and interactions with biological targets. This research can lead to insights into the design and synthesis of new molecules with improved pharmacological profiles.
Check Digit Verification of cas no
The CAS Registry Mumber 1264870-22-5 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,6,4,8,7 and 0 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 1264870-22:
(9*1)+(8*2)+(7*6)+(6*4)+(5*8)+(4*7)+(3*0)+(2*2)+(1*2)=165
165 % 10 = 5
So 1264870-22-5 is a valid CAS Registry Number.
1264870-22-5Relevant articles and documents
ANTIVIRAL COMPOUNDS AND METHODS OF MAKING AND USING THERE OF CROSS REFERENCE TO RELATED APPLICATIONS
-
, (2011/02/24)
Compounds which exhibit antiviral activity, particularly against influenza virus,and methods of making and using there of are described herein. In one embodiment, the compounds are heterocyclic amides containing piperazine and isozazole rings and optionally substituted with one or more substituents. The compounds can be formulated with one or more pharmaceutically acceptable excipients to form compositions suitable for enteralor parenteral administration. The compounds are preferably used to treat or prevent Influenza Ainfections, such as H1N1, H2N2, H3N2, H5N1, H7N7, H1N2, H9N2, H7N2, H7N3, and H10N7.